跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tobaren - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tobaren
Approved
STANDARD
Tobaren
Samchundang Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b4f6a857ea4b1a15
Company
Samchundang Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
b4f6a857ea4b1a15
Drug Approval Philippines Name
Tobaren
Product Name
Tobaren
Registration Number
DRP-8919
Brand Name
Tobaren
Generic Name
Tobramycin + Dexamethasone
Dosage Form
Sterile Ophthalmic Suspension (Eye Drops)
Dosage Strength
3 mg / 1 mg per Ml (0.3%/0.1% w/v)
Manufacturer
Samchundang Pharm. Co., Ltd.
Importer
I-Senz Medical Inc
Distributor
I-Senz Medical Inc
Company Detail Path
/organization/samchundang-pharm-co-ltd
Issuance Date
16 April 2025
Expiry Date
24 June 2031
Pharmacologic Category
Antibacterial (Aminoglycoside) / Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b4f6a857ea4b1a15
Type
Standard
Back to Philippines FDA Approvals